Tempus AI, Inc. - TEM
About Gravity Analytica
Recent News
- 09.17.2025 - AI in oncology: Fundamentals to full integration into your practice
- 09.15.2025 - Minimal residual disease (MRD) testing: A practical guide for clinicians
- 09.11.2025 - Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device
- 09.11.2025 - Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device
- 09.11.2025 - Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device
- 09.09.2025 - Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer
- 09.09.2025 - Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer
- 09.09.2025 - Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer
- 09.08.2025 - Morgan Stanley 23nd Annual Global Healthcare Conference
- 09.08.2025 - Morgan Stanley 23nd Annual Global Healthcare Conference